The present invention relates to the identification of lipid oxidising
antibodies as a key pathogenic factor in atherosclerotic disorders. These
disorders may be treated by inhibiting this antibody mediated lipid
oxidation and methods and means for identifying and producing inhibitory
agents are provided.